Episode

Video Episode 64 - Professor Justin Stebbing

Podcast: Few & Far Between: How Biotech Gets Built
Published: Nov 11, 2025
Duration seconds: 2850
Processing state: not_requested
Canonical source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-64-professor-justin-stebbing
Audio: https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2202607/c1e-rd2d1hwvo8oa4r23gg-wwpwj4j0t1pg-cd9ajy.mp4
JSON: /v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/video-episode-64-professor-justin-stebbing
Markdown: /podcast/few-far-between-how-biotech-gets-built-4067896/video-episode-64-professor-justin-stebbing.md

Actions

POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/video-episode-64-professor-justin-stebbing/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/video-episode-64-professor-justin-stebbing.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Will GLP-1's one day replace our morning coffee? Find out in a special video episode of the Few & Far Between podcast! Host Chris O'Brien welcomes friend of the show, Professor Justin Stebbing. In this new segment, we'll spotlight biotech trends that you need to know about - from T cells to GLP-1 - and identify which innovations are worth the hype. Let's start the podcast!